(Q34553224)

English

A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit